BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16504688)

  • 1. Influence of cytomegalovirus disease on early and late renal graft function.
    Boratyńska M; Banasik M; Watorek E; Patrzałek D; Szyber P; Klinger M
    Transplant Proc; 2006; 38(1):147-50. PubMed ID: 16504688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
    De Santo LS; Romano G; Mastroianni C; Roberta C; Della Corte A; Amarelli C; Maiello C; Giannolo B; Marra C; Ragone E; Grimaldi M; Utili R; Scardone M; Cotrufo M
    Transplant Proc; 2005; 37(6):2684-7. PubMed ID: 16182784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH; Mao YY; He Q; Wu JY; Lv R
    Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal retransplantation: a retrospective monocentric study.
    Ott U; Busch M; Steiner T; Schubert J; Wolf G
    Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical results of immunosuppressive triple therapies in living-related renal transplantation--a single center experience].
    Nagahama K; Yamamoto S; Yoshida H; Nakamura E; Ito N; Kinoshita H; Kamoto T; Okuno H; Ogawa O
    Hinyokika Kiyo; 2004 Sep; 50(9):605-10. PubMed ID: 15518124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
    Boobes Y; Al Hakim M; Dastoor H; Bernieh B; Abdulkhalik S
    Transplant Proc; 2004; 36(6):1841-3. PubMed ID: 15350493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients.
    Haririan A; Morawski K; West MS; El-Amm JM; Doshi MD; Cincotta E; Alangaden GJ; Chandrasekar P; Gruber SA
    Clin Transplant; 2007; 21(4):466-71. PubMed ID: 17645705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
    Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
    Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
    Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
    Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious complications in kidney transplant recipients: a single-center experience.
    Charfeddine K; Zaghden S; Kharrat M; Kamoun K; Jarraya F; Hachicha J
    Transplant Proc; 2005; 37(6):2823-5. PubMed ID: 16182820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
    Boucher A; Lord H; Collette S; Morin M; Dandavino R
    Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation.
    Li Y; Xue WJ; Tian PX; Ding XM; Yan H; Pan XM; Feng XS
    Transplant Proc; 2009 Jun; 41(5):1565-9. PubMed ID: 19545680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.